This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
At GSK, the Medical Lead, Chronic Hepatitis B (CHB), is responsible for acting as the medical affairs and principal scientific expert for the CHB therapeutic area/disease. This role provides strategic medical affairs leadership for assets (marketed and in development), fosters external scientific engagement, and collaborates across departments to promote the appropriate use of our medicines for Canadian patients.
Job Responsibility:
Lead the scientific and external engagement strategy for the CHB assets/disease area in Canada and drive execution in partnership with MSL Manager, Medical Advisor, and Medical Science Liaisons (MSLs)
Collaborate closely with cross-functional partners (e.g., Market Access, Regulatory, External Affairs, and Commercial) and contribute as a member of the Specialty Care Medical Affairs Leadership team
Recognized as a trusted partner to Commercial by providing medical guidance and input, aligning on engagement strategy, and supporting compliant promotional initiatives
Generate, synthesize, and translate the medical voice of the customer and market into actionable insights that feed into both medical and brand strategy to enable appropriate use of GSK medicines for patients in Canada
Partner with Health Economics and Outcomes Research (HEOR) to generate evidence that demonstrates product value and anticipates the needs of regulators, payers, healthcare professionals (HCPs), and patients
Accelerate research and expand the clinical value of the pipeline by optimizing the clinical–medical partnership and identifying evidence-generation opportunities
Advocate for the data required to support successful commercialization, including support for access, reimbursement, and guidelines where appropriate
Contribute to patient safety by reporting, in a timely manner, all adverse events identified through customer interactions in accordance with internal policies and training, including receipt of follow-up information
Requirements:
MD, PharmD, PhD, or other advanced degree in a scientific/clinical discipline
relevant medical affairs experience may be considered in lieu of specific degree requirements
3-5 years of experience in medical affairs and/or clinical development within pharmaceutical or biotechnology industries
Demonstrated disease-area knowledge in hepatology, infectious diseases, virology, or related therapeutic areas (Chronic Hepatitis B strongly preferred)
Proven ability to lead medical strategy and translate scientific/clinical evidence into actionable plans and insights
Specialty care/precision medicine asset launch experience in the pre, peri and post-launch spaces
Experience partnering cross-functionally (e.g., Commercial, Market Access/HEOR, Regulatory) while maintaining strong compliance and scientific integrity
Strong external engagement capabilities, including scientific exchange with HCPs and key opinion leaders
Excellent communication skills (written, verbal, and presentation) with the ability to influence without authority
Ability to travel within Canada as required
Nice to have:
Experience leading asset or disease-area medical plans at the national level
Experience with evidence generation across RWE, outcomes research, and/or value dossiers in partnership with HEOR and market access
Prior people leadership and/or leadership of matrix teams (e.g., medical advisor team leadership)
Familiarity with the Canadian healthcare environment, including reimbursement pathways, payer evidence needs, and stakeholder landscape
Experience supporting launch readiness and commercialization activities in a compliant manner
Fluency in both English and French (written and spoken)